A combined Single and Multiple Rising Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of SCH900062 in Healthy Adult Volunteers
Completed
- Conditions
- Alzheimer Diseasecognitive dysfunction10009841
- Registration Number
- NL-OMON32905
- Lead Sponsor
- Schering-Plough
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 54
Inclusion Criteria
Males and females
Between 30-60 years of age
Exclusion Criteria
Clinical significant abnormalities for medical examination
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Safety and tolerability</p><br>
- Secondary Outcome Measures
Name Time Method <p>Pharmacokinetics, bioavailability</p><br>